Karen O Richmond, LCSW in Afton, OK - Social Worker

Karen O Richmond, LCSW is a Social Worker - Clinical based in Afton, Oklahoma. Karen O Richmond is licensed to practice in Oklahoma (license number 2607) and her current practice location is 138 S Main, Afton, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (918) 257-4244.

NPI number for Karen O Richmond is 1013954627 and her current mailing address is 138 S. Main, Afton, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013954627.

Contact Information

	Karen O Richmond, LCSW
	138 S Main, Afton, OK 74331-8927
	(918) 257-4244
	(918) 257-4247

Healthcare Provider's Profile

Full Name	Karen O Richmond
Gender	Female
Speciality	Social Worker - Clinical
Location	138 S Main, Afton, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013954627
Provider Enumeration Date: 06/01/2006
Last Update Date: 06/23/2011

Medical Identifiers

Medical identifiers for Karen O Richmond such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013954627	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	2607 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Karen O Richmond is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Karen O Richmond, LCSW 138 S. Main, Afton, OK 74331-8927 Ph: (918) 257-4244	Karen O Richmond, LCSW 138 S Main, Afton, OK 74331-8927 Ph: (918) 257-4244

News Archive

New antidepressants might be no more effective than the best existing drugs

The reviews suggest that sertraline - sold under the brand name Zoloft since 1991- could be the best initial choice of antidepressant in people with acute major depression. The generic formulation produced the best balance of effectiveness, tolerability and purchase price, the authors say.

Mental distress increases among smokers in England during COVID-19 pandemic

Scientists have conducted a survey in England to investigate the association between smoking habits and distress during the COVID-19 pandemic.

Nicotine delivery devices are harmful and do not help smokers to quit

In a new statement published by the European Respiratory Society Tobacco Control Committee, an international coalition of respiratory doctors and scientists have warned that tobacco harm reduction strategies which support the use of alternative nicotine delivery products for smoking cessation are not effective and are based upon incorrect assumptions and undocumented claims.

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.

Cardiac stem cells from sick patients could generate new heart muscle: Research

Cardiac stem cells even in elderly and sick patients could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart Association's Scientific Sessions 2010.

Karen O Richmond, LCSW - Clinical Social Worker in Afton, OK